Decision Support · Side-by-side

EyeArt AI Eye Screening System vs RetinaLyze. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

EyeArt AI Eye Screening System

RetinaLyze

Best overall

For everyday users (non-clinicians), neither tool is directly usable—they are both professional medical devices for eye clinics. RetinaLyze wins for clinics wanting fast, explainable results with telemedicine and broad device support, while EyeArt is a solid but more expensive option for high-volume diabetic retinopathy screening. The single biggest difference: RetinaLyze offers built-in telemedicine and works with 60+ devices, whereas EyeArt requires a dedicated fundus camera and higher upfront investment.

EyeArt AI Eye Screening System

#4942 of 3,826 Web

RetinaLyze

€Custom/mo Web API

Scores at a glance

EyeArt AI Eye Screening SystemRetinaLyzePractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose EyeArt AI Eye Screening System if

You run a high-volume diabetic retinopathy screening clinic and already own a compatible fundus camera
You want a standalone system that doesn't depend on internet connectivity (on-premise software)
You prioritize very high sensitivity/specificity for DR detection over broader disease coverage
You have budget for a significant upfront investment and dedicated staff for image acquisition

Choose RetinaLyze if

You manage a multi-location optometry chain and need a cloud-based solution that works with your existing cameras
You want built-in telemedicine to easily refer patients to ophthalmologists without extra software
You need to screen for multiple conditions (DR, glaucoma, AMD) from both retinal photos and OCT scans
You value explainable AI results (overlays, measurements) to support clinical decisions

Key differences

RetinaLyze supports both retinal photos and OCT scans; EyeArt only works with retinal images
RetinaLyze has an API and integrates with 60+ devices; EyeArt has no API and limited integrations
EyeArt is on-premise software; RetinaLyze is cloud-only (SaaS)
RetinaLyze includes telemedicine features; EyeArt does not
EyeArt's pricing is unknown but likely high upfront; RetinaLyze is subscription-based (€Custom/mo)
RetinaLyze provides explainable overlays; EyeArt gives automated diagnosis reports without visual explanations

Facts side by side

	EyeArt AI Eye Screening System	RetinaLyze
Free plan
Mobile app
API access

EyeArt AI Eye Screening System: strengths & weaknesses

Very high accuracy for detecting diabetic retinopathy
Automated reports reduce need for specialist graders
Fast turnaround helps clinics make quick decisions
Requires buying a special fundus camera and software – expensive upfront
No mobile app or API, so you can't use it on a phone or connect it to other apps
Only works with retinal images, not OCT scans
Pricing is hidden; you must contact sales, which is a hassle

RetinaLyze: strengths & weaknesses

Works with over 60 different cameras and EHR systems – easy to fit into existing clinics
Built-in telemedicine lets you send results to specialists without extra steps
Provides explainable overlays (e.g., cup-to-disc ratio) so doctors can see why the AI flagged something
Compliant with GDPR, HIPAA, and MDR – important for healthcare
Cloud-only – no option to run it on your own servers if you prefer that
Pricing is custom and not transparent; you have to talk to sales
Only works with supported cameras and EHRs – not a plug-and-play for any device

Common questions

Can I use EyeArt or RetinaLyze on my phone?

No. Both are professional medical tools for eye clinics. They require a fundus camera or OCT scanner connected to a computer. Neither has a mobile app.

Which is better for a small optometry practice: EyeArt or RetinaLyze?

RetinaLyze is better for small practices because it works with many existing cameras, has a cloud subscription (lower upfront cost), and includes telemedicine to refer patients easily. EyeArt requires a bigger upfront investment and a dedicated camera.

Do these tools work with my existing eye exam equipment?

RetinaLyze supports over 60 devices and EHR systems, so it likely works with common cameras. EyeArt requires a specific integrated fundus camera – you'll need to check compatibility with your equipment.

Is RetinaLyze worth the price for a clinic?

If you already have a compatible camera and want fast, explainable AI screening with telemedicine, the subscription model can be cost-effective. But since pricing is custom, you need to request a quote to see if it fits your budget.

Can I try EyeArt or RetinaLyze before buying?

Both require contacting sales for demos or trials. There are no free self-service trials available.

Which tool is more accurate for detecting diabetic retinopathy?

Both claim high accuracy. EyeArt emphasizes very high sensitivity and specificity for DR. RetinaLyze also performs well and adds explainable overlays. For a direct accuracy comparison, you'd need to review clinical studies specific to your patient population.

RetinaLyze wins for most clinics thanks to broader device support, telemedicine, and explainable results, while EyeArt is a strong but more expensive niche option for high-volume diabetic retinopathy screening.

If you run an eye clinic and want a flexible, cloud-based AI screening tool that works with many cameras and includes telemedicine, go with RetinaLyze. If you have a dedicated fundus camera and need a high-accuracy, on-premise solution for diabetic retinopathy, EyeArt is a solid choice. For everyday users without a clinic, neither tool is relevant.

Visit EyeArt AI Eye Screening System Visit RetinaLyze

Detail pages: EyeArt AI Eye Screening System · RetinaLyze

EyeArt AI Eye Screening System

RetinaLyze

Free plan

Mobile app

API access